Extensive serum (not plasma) proteomic analysis of COVID-19 patients pointed to the possibility of decrease in FXIII-B in the sera of COVID-19 patients, in a correlation to increase in IL-6 levels [29]. The gene discussed is F13B; the disease is COVID-19.